Abstract
A series of potent specific HIV-1 RT inhibitory compounds is described. The compounds are urea analogs of PETT (PhenylEthylThiazoleThiourea) derivatives and the series includes derivatives with an ethyl linker (1-6) and conformationally restricted analogs (7-13). The antiviral activity is determined both at the RT level and in cell culture on both native and mutant forms of HIV-1. Many compounds display activity in the nM range against wt-RT.
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / metabolism
-
Anti-HIV Agents / pharmacology*
-
Blood Proteins / metabolism
-
Cell Line
-
HIV-1 / drug effects*
-
Humans
-
Microbial Sensitivity Tests
-
Protein Binding
-
Reverse Transcriptase Inhibitors / chemical synthesis*
-
Reverse Transcriptase Inhibitors / metabolism
-
Reverse Transcriptase Inhibitors / pharmacology*
-
Structure-Activity Relationship
-
Thiazoles / chemistry
-
Thiazoles / metabolism
-
Thiazoles / pharmacology*
-
Triazoles / chemistry
-
Triazoles / metabolism
-
Triazoles / pharmacology*
Substances
-
Anti-HIV Agents
-
Blood Proteins
-
Reverse Transcriptase Inhibitors
-
Thiazoles
-
Triazoles
-
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole